keyword
https://read.qxmd.com/read/38629858/inactivation-of-the-ribosome-assembly-factor-rimp-causes-streptomycin-resistance-and-impairs-motility-in-salmonella
#21
JOURNAL ARTICLE
Zhihui Lyu, Yunyi Ling, Ambro van Hoof, Jiqiang Ling
The ribosome is the central hub for protein synthesis and the target of many antibiotics. Although the majority of ribosome-targeting antibiotics inhibit protein synthesis and are bacteriostatic, aminoglycosides promote protein mistranslation and are bactericidal. Understanding the resistance mechanisms of bacteria against aminoglycosides is not only vital for improving the efficacy of this critically important group of antibiotics but also crucial for studying the molecular basis of translational fidelity...
April 17, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38629483/ultra-rapid-selection-of-the-n74d-capsid-inhibitor-resistance-mutation-after-3%C3%A2-weeks-on-lenacapavir
#22
JOURNAL ARTICLE
Marc Wirden, Cecile Pouderoux, Gilles Peytavin, Basma Abdi, Antoine Fayçal, Romain Palich, Marc Antoine Valantin, Sophie Seang, Christine Katlama, Vincent Calvez, Valerie Pourcher, Anne-Geneviève Marcelin
No abstract text is available yet for this article.
April 17, 2024: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/38629469/iron-efflux-by-ieta-enhances-%C3%AE-lactam-aztreonam-resistance-and-is-linked-to-oxidative-stress-through-cellular-respiration-in-riemerella-anatipestifer
#23
JOURNAL ARTICLE
Mafeng Liu, Mengying Wang, Mi Huang, Qun Gao, Dekang Zhu, Mingshu Wang, Renyong Jia, Shun Chen, Xinxin Zhao, Qiao Yang, Ying Wu, Shaqiu Zhang, Juan Huang, Xumin Ou, Sai Mao, Bin Tian, Di Sun, Anchun Cheng
BACKGROUND: Riemerella anatipestifer encodes an iron acquisition system, but whether it encodes the iron efflux pump and its role in antibiotic resistance are largely unknown. OBJECTIVES: To screen and identify an iron efflux gene in R. anatipestifer and determine whether and how the iron efflux gene is involved in antibiotic resistance. METHODS: In this study, gene knockout, streptonigrin susceptibility assay and inductively coupled plasma mass spectrometry were used to screen for the iron efflux gene ietA...
April 17, 2024: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/38629462/pharmacogenetics-of-aminoglycoside-related-ototoxicity-a-systematic-review
#24
JOURNAL ARTICLE
D Gaafar, N Baxter, N Cranswick, J Christodoulou, A Gwee
BACKGROUND: Aminoglycosides (AGs) are important antibiotics in the treatment of Gram-negative sepsis. However, they are associated with the risk of irreversible sensorineural hearing loss (SNHL). Several genetic variants have been implicated in the development of ototoxicity. OBJECTIVES: To evaluate the pharmacogenetic determinants of AG-related ototoxicity. METHODS: This study followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses and was registered on Prospero (CRD42022337769)...
April 17, 2024: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/38629250/triazole-antifungal-drug-interactions-practical-considerations-for-excellent-prescribing
#25
JOURNAL ARTICLE
Russell Lewis, Saarah Niazi-Ali, Andrew McIvor, Souha S Kanj, Johan Maertens, Matteo Bassetti, Deborah Levine, Andreas H Groll, David W Denning
Systemic antifungal therapy is critical for reducing the mortality from many invasive and chronic fungal infections. Triazole antifungals are the most frequently prescribed antifungals but require attention to dosing and drug interactions. Nearly 600 severe drug-drug interactions and over 1100 moderate interactions requiring dose modifications are described or anticipated with systemic antifungal agents (see https://www.aspergillus.org.uk/antifungal-drug-interactions/). In this article, we address the common and less common, but serious, drug interactions observed in clinical practice with triazole antifungals, including a group of drugs that cannot be prescribed with all or most triazole antifungals (ivabradine, ranolazine, eplerenone, fentanyl, apomorphine, quetiapine, bedaquiline, rifampicin, rifabutin, sirolimus, phenytoin and carbamazepine)...
April 17, 2024: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/38629145/inappropriate-prescribing-contributes-to-high-antibiotic-exposure-in-young-children-in-australia
#26
JOURNAL ARTICLE
Stejara A Netea, Nicole L Messina, Kaya Gardiner, Laure F Pittet, Nigel Curtis
BACKGROUND: Antibiotic exposure increases antimicrobial resistance and has also been associated with long-term harms, including allergies, inflammatory diseases and weight gain. We assessed antibiotic exposure in the first 2 years of life in Australian children, the factors influencing this and its appropriateness. METHODS: Data from 1201 participants in the MIS BAIR randomized controlled trial were used. Multivariable logistic regression was used to identify factors associated with antibiotic exposure...
April 17, 2024: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/38629139/occurrence-and-characterization-of-rmtb-harbouring-salmonella-and-escherichia-coli-isolates-from-a-pig-farm-in-the-uk
#27
JOURNAL ARTICLE
Indre Navickaite, Harry Holmes, Letizia Dondi, Luke Randall, Catherine Fearnley, Emma Taylor, Edward Fullick, Robert Horton, Susanna Williamson, Manal AbuOun, Christopher Teale, Muna F Anjum
OBJECTIVES: To characterize and elucidate the spread of amikacin-resistant Enterobacteriaceae isolates from environmental samples on a pig farm in the UK, following the previous identification of index Salmonella isolates harbouring the rmtB gene, a 16S rRNA methylase. METHODS: Environmental samples were collected during two visits to a pig farm in the UK. Isolates were recovered using selective media (amikacin 128 mg/L) followed by real-time PCR and WGS to analyse rmtB-carrying Salmonella and Escherichia coli isolates...
April 17, 2024: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/38624228/genomic-characterization-of-st38-ndm-5-producing-escherichia-coli-isolates-from-an-outbreak-in-the-czech-republic
#28
JOURNAL ARTICLE
Katerina Chudejova, Tsolaire Sourenian, Jana Palkovicova, Katarina Stredanska, Lucie Nechutna, Katerina Vlkova, Vendula Studentova, Jaroslav Hrabak, Costas C Papagiannitsis, Monika Dolejska, Ibrahim Bitar
A 2-year national genomic screening in the Czech Republic identified a notable prevalence of the New Delhi metallo-β-lactamase 5 (NDM-5)-producing Escherichia coli sequence type 38 (ST38) in the city of Brno. Forty-two ST38 E. coli isolates harbored the bla NDM-5 gene on the chromosome. Virulence factors confirmed the persistence of these isolates through biofilm formation. Single Nucleotide Polymorphisms (SNPs)-based phylogeny and CRISPR assay typing showed minimal genomic variations, implying a clonally driven outbreak...
April 16, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38624217/precise-genome-editing-underlines-the-distinct-contributions-of-mutations-in-erg11-erg3-mrr1-and-tac1-genes-to-antifungal-resistance-in-candida-parapsilosis
#29
JOURNAL ARTICLE
Sophie Hartuis, Isabelle Ourliac-Garnier, Estelle Robert, Marjorie Albassier, Léa Duchesne, Clara Beaufils, Joséphine Kuhn, Patrice Le Pape, Florent Morio
Candida parapsilosis has recently emerged as a major threat due to the worldwide emergence of fluconazole-resistant strains causing clonal outbreaks in hospitals and poses a therapeutic challenge due to the limited antifungal armamentarium. Here, we used precise genome editing using CRISPR-Cas9 to gain further insights into the contribution of mutations in ERG11 , ERG3 , MRR1 , and TAC1 genes and the influence of allelic dosage to antifungal resistance in C. parapsilosis . Seven of the most common amino acid substitutions previously reported in fluconazole-resistant clinical isolates (including Y132F in ERG11 ) were engineered in two fluconazole-susceptible C...
April 16, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38624213/correction-for-chen-et-al-repurposing-a-human-acetyl-coa-carboxylase-inhibitor-firsocostat-to-treat-fungal-candidiasis-alone-and-in-combination
#30
JOURNAL ARTICLE
Tianyu Chen, Jing Yao, Keao Quan, Jingchen Xu, Xudong Hang, Qian Tong, Genyan Liu, Peipei Luo, Liping Zeng, Ganzhu Feng, Hongkai Bi
No abstract text is available yet for this article.
April 16, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38619253/evaluation-and-activity-of-new-porphyrin-peptide-cage-type-conjugates-for-the-photoinactivation-of-mycobacterium-abscessus
#31
JOURNAL ARTICLE
Matthéo Alcaraz, Sébastien Lyonnais, Chandramouli Ghosh, John Jairo Aguilera-Correa, Sébastien Richeter, Sébastien Ulrich, Laurent Kremer
Mycobacterium abscessus is increasingly recognized as an emerging opportunistic pathogen causing severe lung diseases and cutaneous infections. However, treatment of M. abscessus infections remains particularly challenging, largely due to intrinsic resistance to a wide panel of antimicrobial agents. New therapeutic alternatives are urgently needed. Herein, we show that, upon limited irradiation with a blue-light source, newly developed porphyrin-peptide cage-type photosensitizers exert a strong bactericidal activity against smooth and rough variants of M...
April 15, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38619252/combination-of-ganciclovir-and-trifluridine-prevents-drug-resistance-emergence-in-hsv-1
#32
JOURNAL ARTICLE
Hanna Helena Schalkwijk, Neesha Rajesh Shewakramani, Kalyan Das, Graciela Andrei, Robert Snoeck
Ocular herpes simplex virus 1 (HSV-1) infections can lead to visual impairment. Long-term acyclovir (ACV) prophylaxis reduces the frequency of recurrences but is associated with drug resistance. Novel therapies are needed to treat drug-resistant HSV-1 infections. Here, we describe the effects of trifluridine (TFT) in combination with ACV or ganciclovir (GCV) on HSV-1 replication and drug-resistance emergence. Wild-type HSV-1 was grown under increasing doses of one antiviral (ACV, GCV, or TFT) or combinations thereof (ACV + TFT or GCV + TFT)...
April 15, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38619055/accumulibacter-spp-as-the-origin-of-the-oxa-198-carbapenemase-gene-cassette
#33
JOURNAL ARTICLE
Aymeric Jacquemin, Thierry Naas, Laurent Dortet, Rémy A Bonnin
No abstract text is available yet for this article.
April 15, 2024: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/38618451/a-rare-case-of-extranodal-natural-killer-t-cell-lymphoma-nasal-type-associated-with-hemophagocytic-lymphohistiocytosis-in-a-patient-with-recurrent-sinusitis
#34
Bryce R Christensen, Chung-Ting J Kou, Lauren E Lee
We present a rare case of hemophagocytic lymphohistiocytosis (HLH) secondary to nasal-type extranodal natural killer/T-cell lymphoma (ENKL). Nasal-type ENKL is a rare subtype of non-Hodgkin's lymphoma usually associated with Epstein-Barr virus (EBV). The patient was a 19-year-old woman who presented with facial numbness, diminished hearing, and dysgeusia. She was febrile with palatal necrosis, loss of gag reflex, and cranial nerve palsies. Labs revealed neutropenia. Broad-spectrum antimicrobials, including amphotericin, were started...
March 2024: Curēus
https://read.qxmd.com/read/38606975/effect-modification-of-dosing-strategy-auc-or-trough-on-aki-associated-with-vancomycin-in-combination-with-piperacillin-tazobactam-or-cefepime-and-meropenem
#35
JOURNAL ARTICLE
Breanne Mefford, Katie L Wallace, J Chris Donaldson, Brittany D Bissell Turpin, Parijat Sen, Aric D Schadler, Lucas J Liu, Melissa L Thompson Bastin
Piperacillin-tazobactam (TZP), cefepime (FEP), or meropenem (MEM) and vancomycin (VAN) are commonly used in combination for sepsis. Studies have shown an increased risk of acute kidney injury (AKI) with TZP and VAN compared to FEP or MEM. VAN guidelines recommend area under the curve (AUC) monitoring over trough (Tr) to minimize the risk of AKI. We investigated the association of AKI and MAKE-30 with the two VAN monitoring strategies when used in combination with TZP or FEP/MEM. Adult patients between 2015 and 2019 with VAN > 72 hours were included...
April 12, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38606836/daptomycin-and-ceftaroline-combination-for-the-treatment-of-persistent-methicillin-resistant-staphylococcus-aureus-bloodstream-infections-a-case-series-and-literature-review
#36
JOURNAL ARTICLE
Yazed S Alsowaida, Ahmed Alsolami, Thamer A Almangour
Methicillin-resistant Staphylococcus aureus (MRSA) is challenging to treat due to a lack of guidance for clinicians. The daptomycin and ceftaroline combination is promising for treating persistent MRSA bloodstream infections (BSIs). In this report, we present a case series of 7 patients who failed vancomycin and then were treated with daptomycin and ceftaroline for persistent MRSA BSIs. The median age (IQR) of the included patients was 59 (48-67), with 5 male and 2 female patients. Six patients (85.7%) had a clinical cure for their persistent BSIs...
April 12, 2024: Journal of Chemotherapy
https://read.qxmd.com/read/38602418/difficult-to-treat-dtr-pseudomonas-aeruginosa-harboring-verona-integron-metallo-%C3%AE-lactamase-bla-vim-infection-management-and-molecular-analysis
#37
JOURNAL ARTICLE
Ana D Vega, Kailynn DeRonde, Adriana Jimenez, Michael Piazza, Christine Vu, Octavio Martinez, Laura J Rojas, Steven Marshall, Mohamad Yasmin, Robert A Bonomo, Lilian M Abbo
Pseudomonas aeruginosa harboring Verona Integron-encoded metallo-β-lactamase enzymes (VIM-CRPA) have been associated with infection outbreaks in several parts of the world. In the US, however, VIM-CRPA remain rare. Starting in December 2018, we identified a cluster of cases in our institution. Herein, we present our epidemiological investigation and strategies to control/manage these challenging infections. This study was conducted in a large academic healthcare system in Miami, FL, between December 2018 and January 2022...
April 11, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38602413/naphthylisoquinoline-alkaloids-novel-agents-against-the-causative-pathogens-of-eumycetoma-and-actinomycetoma-en-route-to-broad-spectrum-antimycetomal-drugs
#38
JOURNAL ARTICLE
Sami Ahmed Khalid, Shereen Abd Algaffar, Nasir Tajuddeen, Blaise Kimbadi Lombe, Gerhard Bringmann
Mycetoma is a devastating neglected tropical infection of the subcutaneous tissues. It is caused by fungal and bacterial pathogens recognized as eumycetoma and actinomycetoma, respectively. Mycetoma treatment involves diagnosing the causative microorganism as a prerequisite to prescribing a proper medication. Current therapy of fungal eumycetoma causative agents, such as Madurella mycetomatis , consists of long-term antifungal medication with itraconazole followed by surgery, yet with usually unsatisfactory clinical outcomes...
April 11, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38601919/-in-vitro-evaluation-of-the-binding-activity-of-novel-mouse-igg1-opsonic-monoclonal-antibodies-to-mycobacterium-tuberculosis-and-other-selected-mycobacterial-species
#39
JOURNAL ARTICLE
Kudzai B Nyazema, Bong-Akee Shey, Clara J Sei, Remco P H Peters, Nontuthuko E Maningi, Gerald W Fischer, P Bernard Fourie
Antimicrobial resistance alongside other challenges in tuberculosis (TB) therapeutics have stirred renewed interest in host-directed interventions, including the role of antibodies as adjunct therapeutic agents. This study assessed the binding efficacy of two novel IgG1 opsonic monoclonal antibodies (MABs; GG9 & JG7) at 5, 10, and 25 µg/mL to live cultures of Mycobacterium tuberculosis, M. avium , M. bovis , M. fortuitum , M. intracellulare , and M. smegmatis American Type Culture Collection laboratory reference strains, as well as clinical susceptible, multi-drug resistant, and extensively drug resistant M...
May 2024: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
https://read.qxmd.com/read/38598696/genetic-determinants-of-resistance-to-antimicrobial-therapeutics-are-rare-in-publicly-available-clostridioides-difficile-genome-sequences
#40
JOURNAL ARTICLE
Baban Kolte, Ulrich Nübel
OBJECTIVES: To determine the frequencies and clonal distributions of putative genetic determinants of resistance to antimicrobials applied for treatment of Clostridioides difficile infection (CDI), as documented in the genomic record. METHODS: We scanned 26 557 C. difficile genome sequences publicly available from the EnteroBase platform for plasmids, point mutations and gene truncations previously reported to reduce susceptibility to vancomycin, fidaxomicin or metronidazole, respectively...
April 10, 2024: Journal of Antimicrobial Chemotherapy
keyword
keyword
61774
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.